Oncotarget

Vol 12, No 4

February 16, 2021

View Archive »

Order a Reprint

About The Cover

The cover for issue 4 of Oncotarget features Figure 2, "18F-FES PET/CT images from patient 40 with serous ovarian cancer," by Takebe, et al.

Table of Contents

Editorial

Data driven precision medicine: who is the driver?

Data driven precision medicine: who is the driver?

https://doi.org/10.18632/oncotarget.27860

Sebastian Klein,  and Reinhard Büttner
253-254
PDF  |  How to cite  |  Order a Reprint

Research Papers

Krüppel-like factor 4 promotes survival and expansion in acute myeloid leukemia cells

Krüppel-like factor 4 promotes survival and expansion in acute myeloid leukemia cells

https://doi.org/10.18632/oncotarget.27878

Andrew Henry Lewis, Cory Seth Bridges, Viraaj Singh Punia, Abraham Fausto Jornada Cooper, Monica Puppi,  and H. Daniel Lacorazza
255-267
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite  |  Order a Reprint

Phase 1 study of Z-endoxifen in patients with advanced gynecologic, desmoid, and hormone receptor-positive solid tumors

Phase 1 study of Z-endoxifen in patients with advanced gynecologic, desmoid, and hormone receptor-positive solid tumors

https://doi.org/10.18632/oncotarget.27887

Naoko Takebe, Geraldine O'Sullivan Coyne, Shivaani Kummar, Jerry Collins, Joel M. Reid, Richard Piekarz, Nancy Moore, Lamin Juwara, Barry C. Johnson, Rachel Bishop, Frank I. Lin, Esther Mena, Peter L. Choyke, M. Liza Lindenberg, Larry V. Rubinstein, Cecilia Monge Bonilla, Matthew P. Goetz, Matthew M. Ames, Renee M. McGovern, Howard Streicher, Joseph M. Covey, James H. Doroshow,  and Alice P. Chen
268-277
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite  |  Press Release  |  Order a Reprint

Reg4 and its downstream transcriptional activator CD44ICD in stage II and III colorectal cancer

Reg4 and its downstream transcriptional activator CD44ICD in stage II and III colorectal cancer

https://doi.org/10.18632/oncotarget.27896

Jared A. Sninsky, Kumar S. Bishnupuri, Iván González, Nikolaos A. Trikalinos, Ling Chen,  and Brian K. Dieckgraefe
278-291
Abstract  |  PDF  |  Full Text  |  How to cite  |  Order a Reprint

Intratumoral immunotherapy with STING agonist, ADU-S100, induces CD8+ T-cell mediated anti-tumor immunity in an esophageal adenocarcinoma model

Intratumoral immunotherapy with STING agonist, ADU-S100, induces CD8+ T-cell mediated anti-tumor immunity in an esophageal adenocarcinoma model

https://doi.org/10.18632/oncotarget.27886

Ali H. Zaidi, Ronan J. Kelly, Anastasia Gorbunova, Ashten N. Omstead, Madison S. Salvitti, Ping Zheng, Juliann E. Kosovec, Soyoung Lee, Shahin Ayazi, Laila Babar, Gene G. Finley, Ajay Goel,  and Blair A. Jobe
292-303
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite  |  Order a Reprint

Low concentrations of vorinostat decrease EB1 expression in GBM cells and affect microtubule dynamics, cell survival and migration

Low concentrations of vorinostat decrease EB1 expression in GBM cells and affect microtubule dynamics, cell survival and migration

https://doi.org/10.18632/oncotarget.27892

Thomas Perez, Raphaël Bergès, Hélène Maccario, Sarah Oddoux,  and Stéphane Honoré
304-315
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite  |  Order a Reprint

Head to head evaluation of second generation ALK inhibitors brigatinib and alectinib as first-line treatment for ALK+ NSCLC using an in silico systems biology-based approach

Head to head evaluation of second generation ALK inhibitors brigatinib and alectinib as first-line treatment for ALK+ NSCLC using an in silico systems biology-based approach

https://doi.org/10.18632/oncotarget.27875

Enric Carcereny, Alonso Fernández-Nistal, Araceli López, Carmen Montoto, Andrea Naves, Cristina Segú-Vergés, Mireia Coma, Guillem Jorba, Baldomero Oliva,  and Jose Manuel Mas
316-332
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite  |  Podcast  |  Order a Reprint

The interaction between cancer associated fibroblasts and tumor associated macrophages via the osteopontin pathway in the tumor microenvironment of hepatocellular carcinoma

The interaction between cancer associated fibroblasts and tumor associated macrophages via the osteopontin pathway in the tumor microenvironment of hepatocellular carcinoma

https://doi.org/10.18632/oncotarget.27881

Kazunori Tokuda, Yuji Morine, Katsuki Miyazaki, Shinichiro Yamada, Yu Saito, Masaaki Nishi, Takuya Tokunaga, Tetsuya Ikemoto, Satoru Imura,  and Mitsuo Shimada
333-343
Abstract  |  PDF  |  Full Text  |  How to cite  |  Order a Reprint

Oncolytic virotherapy with SOCS3 enhances viral replicative potency and oncolysis for gastric cancer

Oncolytic virotherapy with SOCS3 enhances viral replicative potency and oncolysis for gastric cancer

https://doi.org/10.18632/oncotarget.27873

Shuichi Matsumura, Mikihito Nakamori, Toshiaki Tsuji, Tomoya Kato, Masaki Nakamura, Toshiyasu Ojima, Hiroshi Fukuhara, Yasushi Ino, Tomoki Todo,  and Hiroki Yamaue
344-354
Abstract  |  PDF  |  Full Text  |  How to cite  |  Order a Reprint

Quercetin shortened survival of radio-resistant B-1 cells in vitro and in vivo by restoring miR15a/16 expression

Quercetin shortened survival of radio-resistant B-1 cells in vitro and in vivo by restoring miR15a/16 expression

https://doi.org/10.18632/oncotarget.27883

Yasmim Alefe Leuzzi Ramos, Olivia Fonseca Souza, Marilia Campos Tavares Novo, Caroline Ferreira Cunha Guimarães,  and Ana Flavia Popi
355-365
Abstract  |  PDF  |  Full Text  |  How to cite  |  Order a Reprint

Folic acid supplementation acts as a chemopreventive factor in tumorigenesis of hepatocellular carcinoma by inducing H3K9Me2-dependent transcriptional repression of LCN2

Folic acid supplementation acts as a chemopreventive factor in tumorigenesis of hepatocellular carcinoma by inducing H3K9Me2-dependent transcriptional repression of LCN2

https://doi.org/10.18632/oncotarget.27136

Yin-Ling Zhang, Geng Xue, Hui Miao, Chuan-Chuan Zhou, Shu-Han Sun,  and Yi Zhang
366-378
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite  |  Order a Reprint

Reviews

Extrahepatic cytochrome P450 epoxygenases: pathophysiology and clinical significance in human gastrointestinal cancers

Extrahepatic cytochrome P450 epoxygenases: pathophysiology and clinical significance in human gastrointestinal cancers

https://doi.org/10.18632/oncotarget.27893

Nataliya Pidkovka, Olena Rachkevych,  and Abbes Belkhiri
379-391
Abstract  |  PDF  |  Full Text  |  How to cite  |  Order a Reprint

Corrections

Correction: Comparison of the expression and function of Lin28A and Lin28B in colon cancer

Correction: Comparison of the expression and function of Lin28A and Lin28B in colon cancer

https://doi.org/10.18632/oncotarget.27903

Tianzhen Wang, Yan He, Yuanyuan Zhu, Mingwei Chen, Mingjiao Weng, Chao Yang, Yan Zhang, Ning Ning, Ran Zhao, Weiwei Yang, Yinji Jin, Jing Li, Riju James Rajkumar Ezakiel Redpath, Lei Zhang, Xiaoming Jin, Zhaohua Zhong, Fengmin Zhang, Yunwei Wei, Guomin Shen, Dong Wang, Ying Liu, Guangyu Wang,  and Xiaobo Li
392-393
Correction  |  PDF  |  How to cite


Copyright © 2021 Impact Journals, LLC
Impact Journals is a registered trademark of Impact Journals, LLC